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The intermediate filament proteins desmin and vimentin and the muscle 
tropomyosins were the major protein phosphate acceptors in 8-day-old myotubes 
incubated for 4 h in medium containing radiolabeled phosphate. The addition of 
isoproterenol or 8-bromo-cyclic AMP (BrcAMP) resulted in a two- to threefold 
increase in incorporation of 32P04 into both desmin and vimentin, whereas no 
changes in the incorporation of 32P04 into tropomyosin or other cellular proteins 
were observed. The BrcAMP- or hormonally induced increase in 32P04 incorpo-
ration into desmin and vimentin was independent of protein synthesis and was not 
caused by stimulation of protein phosphate turnover. In addition, BrcAMP did not 
induce significant changes in the specific activity of the cellular A TP pool. These 
data suggest that the observed increase in 32P04 incorporation represented an 
actual increase in phosphorylation of the intermediate filament proteins desmin 
and vimentin. Two-dimensional tryptic analysis of desmin from 8-day-old myo-
tubes revealed five phosphopeptides of which two showed a 7- to 10-fold increase 
in 32P04 incorporation in BrcAMP-treated myotubes. Four of the phosphopep-
tides identified in desmin labeled in vivo were also observed in desmin phosphory-
lated in vitro by bovine heart cAMP-dependent protein kinase. Although phos-
phorylation of desmin and vimentin was apparent in myogenic cells at all stages of 
differentiation, BrcAMP- and isoproterenol-induced increases in phosphorylation 
of these proteins were restricted to mature myotubes. These data strongly suggest 
that in vivo phosphorylation of the intermediate filament proteins desmin and 
vimentin is catalyzed by the cAMP-dependent protein kinases and that such 
phosphorylation may be regulated during muscle differentiation. 
Cytoplasmic filaments with diameters of 9 to 
12 nm have been described in a wide variety of 
cell types from diverse sources. Known collec-
tively as intermediate filaments (IFs), they com-
prise a heterogeneous class of filaments which, 
although similar in morphology, are composed 
of one or more biochemically distinct subunit 
proteins. It is now recognized that a cell may 
possess one or more subclasses of IFs whose 
expression is determined by the tissue of origin 
and state of differentiation (for a review, see 
reference 14). Avian embryonic myotubes cul-
tured in vitro possess two IF proteins (1, 6, 7, 9): 
desmin, the IF protein first isolated from smooth 
muscle (12, 23); and vimentin, which is com-
monly found in fibroblastic cells (7). In imma-
ture skeletal myotubes these two IF proteins 
coexist in an extensive network of cytoplasmic 
filaments (1, 9). Late in myogenesis, however, 
both of these IF proteins become associated 
with the Z lines of myofibril bundles (9), where 
they form a collar-like lattice surrounding and 
interlinking Z discs of adjacent myofibrils (10, 
11). The molecular regulatory mechanisms un-
derlying this redistribution of IFs during myo-
genesis remain obscure. One common biochemi-
cal characteristic of all IFs is phosphorylation of 
their subunit proteins (14). Protein phosphoryla-
tion and dephosphorylation are known to be 
important regulatory events in many cellular 
metabolic processes (13), and it is possible that 
similar mechanisms may be involved in the 
regulation of cellular architecture (22). 
A growing body of evidence suggests that 
phosphorylation ofiF proteins may be modulat-
ed by cyclic AMP (cAMP). Phosphorylation of 
vimentin in S49 cells is enhanced by treatment 
with P-adrenergic agonists or cAMP analogs and 
is deficient in mutant cells lacking functional 
cAMP-dependent protein kinase (25). Similarly, 
C6 glioma-neuroblastoma hybrids show in-
creased phosphorylation ofvimentin when treat-
ed with norepinephrine (2). We have previously 
found that both desmin and vimentin, the IF 
proteins found in avian skeletal myotubes, are 
phosphorylated by cAMP-dependent protein ki-
nase in vitro (20). In this paper we present 
evidence that phosphorylation of desmin and 
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vimentin in chicken embryonic skeletal myo-
tubes is stimulated by p..adrenergic hormones or 
by 8-bromo-cAMP (BrcAMP), resulting in in-
creased phosphorylation of specific desmin tryp-
tic peptides. In addition, we report that the 
response of cultured myogenic cells to hor-
mones or BrcAMP depends upon the state of 
differentiation of these cells. 
MATERIALS AND METHODS 
Carrier-free 32p()4 (orthophosphate in 0.1 N HCI) 
and Aquasol II scintillation fluid were obtained from 
New England Nuclear Corp. Norepinephrine (DL-
arterenol) was obtained from Calbiochem. Trypsin-
tolylsulfonyl phenylalanyl chloromethyl ketone 
(TPCK) was from Worthington Diagnostics. Cellulose 
plates for thin-layer chromatography were obtained 
from Eastman Chemical Products, Inc. (no. 13255). ±-
Isoproterenol, theophylline, BrcAMP, 8-bromo-gua-
nosine 3' ,S' -phosphate (BrcGMP), 8-bromo-adenosine 
S'-monophosphate (BrAMP), and catalytic subunit 
from bovine heart cAMP-dependent protein kinase 
were obtained from Sipla Chemical Co. Sources for 
the electrophoresis reagents have been described pre-
viously (12). 
Cel adtares. Cultures of embryonic myogenic cells 
were prepared from 10-day-old chicken embryos as 
previously described (9). Cultures used for experi-
ments within 24 h of plating were seeded at S x 11)3 to 7 
x 10' cells per 60-mm collagen-coated petri plate. 
Other myogenic cultures were seeded at 2 x 10' to 3 x 
10' cells per 60-mm collagen-coated plate, except as 
noted. Myotube cultures were treated with 10 or 20 
JLM cytosine ara.binofuranoside on days 4 to 7 to 
prevent overgrowth by residual fibroblastic cells. 
Greater than 7S% of the cell nuclei were present in 
multinucleate myotubes in cultures used for these 
experiments. 
32p()4 1Dcabldioall. Duplicate cultures in 60-mm petri 
plates were washed twice with 3 ml of phosphate-free 
minimal essential medium and incubated for 4 h in 
phosphate-free minimal medium supplemented with 
1% horse serum containing 32P04 (SO p.Cilml). Hor-
mones or cAMP analogs were added to the final 
concentrations indicated for 4S min (or indicated time) 
before the end of the 4 h 32p()4 incubation. Labeled 
cultures were washed once with cold phosphate-buff-
ered saline (0.14 M NaCI, 3 mM KCI, 10 mM sodium-
potassium phosphate [pH 7.2]), scraped from petri 
dishes with a rubber policeman, and pelleted at top 
speed in a tabletop centrifuge (International Equip-
ment Co.) (approximately 1,000 x g). Cell pellets were 
then solubilized for 3 to S min at 100"C in 7S p.l of 
sample buffer containing 0.2% sodium dodecyl sulfate 
(SDS), SO mM Tris-hydrochloride (pH 6.8), 1% 2-
mercaptoethanol, and 1S% glycerol. Samples were 
then prepared immediately for electrophoresis (see 
below) or frozen at -20"C for later use. 
'fwo.dbDeasloal electrophoresis In using the O'Far-
rell two-dimensional isoelectric-focusing SDS-poly-
acrylamide gel electrophoresis (IEF/SDS-PAGE) tech-
nique (21), we found that vimentin is particularly 
sensitive to degradation by endogenous proteases 
when present in urea extracts. This proteolysis was 
resistant to most of the common protease inln"biton or 
divalent cation chelating agents but could be prevent-
ed by solubilization in buffen containing 0.2% SDS for 
2 to S min at 100"C. Hydrolysis of protein phosphate 
by phosphatase activity is also minimized by this 
procedure. These SDS-treated whole cell extracts 
were then cooled on ice and mixed with equal volumes 
of saturated urea solution. Duplicate 10-p.l portions 
were taken to determine trichloroacetic acid (TCA)-
precipitable radioactivity (see below). 
Each sample (1 x 10' to 2 x 10' cpm; approximately 
100 to 1SO p.l) was electrophoresed on 10-cm O'Farrell 
isoelectric-focusing gels modified by the omission of 
nonionic detergent. The second (SDS-PAGE) dimen-
sion was performed as previously described (12). Gels 
were stained, destained overnight, dried, and autora-
diographed for the indicated times on Kodak XR-A 
film and Du Pont Cronex Lightning Plus intensifying 
screens. Although the overall isoelectric focusing of 
proteins from SDS-treated myotubes was comparable 
to that seen in O'Farrell gels (Fig. 1), some differences 
were noted. Most obvious was the appearance of a 
prominent S2,00Cklalton protein (slightly more basic 
than vimentin) which was not seen in urea-Nonidet P-
40 extracts of myotubes (inset, Fig. 1C). Whether this 
species represents an artifactual modification of vi-
mentin has not yet been determined. Additionally, the 
tubulins were much less conspicuous in SDS-treated 
extracts. However, the proteolytic degradation was 
substantially reduced in the SDS-treated extract, al-
lowing a more accurate assessment of changes in the 
phosphorylation of this protein. 
For quantitation of 32P04 incorporation into specific 
proteins, individual gel slices were cut out and counted 
in Aquasol with an efficiency of approximately 9S%. 
DetermiDatioa of TeA-precipitable 32p()4 incorpo-
nlioa. Duplicate samples (10 p.l) were spotted on 
Wbatman 3 MM filter disks. Filten were washed for 
20 min in 10% TCA at 90"C and then at room tempera-
ture for 1S min in each of the following: 10% TCA, two 
washes of S% TCA, two washes of9S% ethyl alcohol, 
and two washes of ethyl ether. Filten were dried and 
counted in Aquasol II. 
'fwo.dbDeasloal trypdc mappblg. Two-dimensional 
tryptic mapping of 32P04-labeled desmin and vimentin 
was performed essentially as described previously 
(19). Myotubes (8 days old; 10'1 cells per 100-mm plate) 
were labeled as described above for 4 h with 100 p.Ci of 
32P04 per mi. BrcAMP or BrAMP was added during 
the last hour of the labeling period. IEF/SDS-poly-
acrylamide gels were stained and then destained over-
night, and the appropriate proteins were excised. Gel 
slices were washed for 12 to 24 h in three SOO-ml 
changes of 10% ethanol and for 2 h in 95% ethanol and 
then vacuum dried. Driecr gel slices were rehydrated in 
200 mM ammonium bicarbonate containing 0.2 mg of 
trypsin-TPCK per mi. Approximately 10 p.l of trypsin 
in bicarbonate buffer was added per 1-mm3 dried gel 
slice. Digestion was carried out for 8 to 12 h at 37"C, 
and then an aliquot of trypsin in 1 ml of bicarbonate 
buffer was added. Digestion and peptide elution were 
continued at 37"C for 18 to 24 h, followed by lyophili-
zation of the supernatant. Samples (approximately 
equal amounts of protein representing SOO to 2,000 
epm) were spotted onto cellulose thin-layer plates and 
electrophoresed at 800 V for 45 min in acetic acid:for-
mic acid:water (11.4:10:379), pH 1.9. After being dried 
for 2 h, the plates were chromatographed in butanol: 
acetic acid:pyridine:water (60:12:40:48) for the second 
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dimension. The locations of phosphopeptides were 
determined by authoradiography. Quantitation of 
phosphopeptides was accomplished by scintillation 
counting in Aquasol II, with an efficiency of approxi-
mately 95%. 
Preparation of desmin labeled in vitro by bovine 
heart cAMP-dependent protein kinase was done as 
described by O'Connor et al. (20). 
RESULTS 
Phosphorylation or desmio and vimentin in 8-
day-old myotubes. We have previously shown 
that the IF proteins desmin and vimentin are 
phosphorylated in avian embryonic myotubes 
cultured in vitro, and that both phosphorylated 
and nonphosphorylated species of these proteins 
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are components of the Triton-KCl-insoluble 
myotube cytoskeleton (18) . For this report we 
examined the 32P-labeled phosphoproteins from 
8-day-old myotubes by two-dimensional IEF/ 
SDS-PAGE (Fig. 1). The protein species most 
prominently labeled in myotubes of this age are 
the muscle tropomyosins and two proteins we 
previously identified as the IF proteins desmin 
and vimentin, based upon their electrophoretic 
mobility, isoelectric point, and their enrichment 
in Triton-KCl-treated cytoskeletons of myo-
tubes (8). Several other less heavily labeled 
phosphoproteins were also observed, as well as 
a large amount of radioactive phosphate-con-
taining material which did not focus in the IEF 
gel, remaining near the basic end (top) of the gel. 
Tm 
B 
Tm 
D 
FIG. 1. Two-dimensional IEF/SDS-PAGE analysis of phosphorylation of IF proteins in control and isopro-
terenol-treated 8-day-old myotubes. (A and B) Stained gel and corresponding autoradiogram (12-h exposure) 
from myotubes labeled with 32P04 • lsoelectric focusing is from right to left (basic to acid) in all of the gels 
presented. The approximate pH range is shown in A. SDS-PAGE is from top to bottom. The positions of the 
three desmin species (a', a- and p-D), vimentins (V, arrow), tropomyosins (Tm), actins (Ac), and tubulins (Tb) 
are shown. The asterisks denote an unidentified protein seen in SDS-treated but not in Nonidet P-40-treated 
extracts of myotubes (see the text). The autoradiogram (B) reveals that tropomyosins, a-desmin, and an acidic 
vimentin species (arrow) are the ~or phosphate acceptors. (C and D) No differences are apparent in the protein 
composition observed in myotubes treated with 1 j.LM isoproterenol, as shown by Coomassie-stained gel (C). The 
corresponding autoradiogram reveals increased incorporation of 32P04 into vimentin and desmins (a- and a '-
desmin), but not into other cellular phosphoproteins (such as tropomyosin). The inset in C shows a portion of an 
IEF/SDS-PAGE gel of a myotube urea extract exhibiting substantial proteolysis of vimentin (stars). 
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This material may represent 32P-labeled, poorly 
solubilized protein. 
Direct comparison of the autoradiogram with 
the stained gel (Fig. 1A and B) revealed that (as 
previously reported; 18) u-desmin was the most 
heavily labeled desmin species, with a lesser 
amount of 32P04 incorporation into the more 
acidic u'-desmin, and no label in ~-desmin. 
Similarly, 32P04 incorporation was greatest into 
a single acidic variant of vimentin, with slight 
incorporation into a second, poorly resolved, 
more acidic variant, and no label in the major, 
most basic vimentin species. These results sug-
gested that the acidic variants of desmin and 
vimentin are derived by post-translational phos-
phorylation of the respective more basic protein 
species (17, 20; see below). 
~-Adrenergic agooists increase incorporation 
of 32P04 into IF proteins. Addition of 1 JLM 
isoproterenol during the last 45 min of the 4-h 
32P04 incubation period resulted in specific in-
creases in the incorporation of 32P04 into the IF 
proteins desmin and vimentin (Fig. 1C and D). 
However, isoproterenol did not induce signifi-
cant changes in the protein composition of treat-
ed myotubes as determined by Coomassie blue 
staining (compare Fig. 1A and C). No changes in 
the incorporation of 32P04 into other cellular 
proteins, notably the muscle tropomyosins, 
were apparent under these conditions. Quantita-
tion of excised 32P-labeled protein spots from 
eight experiments revealed that tropomyosin 
contained 0.2 ± 0.1% of the total TeA-precipita-
ble 32P04 in the control myotubes and 0.2 ± 
0.1% of the total TCA-precipitable 32P04 in the 
isoproterenol-treated cells. We thus used 32P04 
incorporation into tropomyosin as an internal 
standard to normalize differences in gel loading 
between each experiment. These results and the 
equation used for their calculation are shown in 
Table 1. Incorporation of 32P04 into desmin and 
vimentin was found to be stimulated approxi-
mately twofold in 8-day-old myotubes treated 
with 1 JLM isoproterenol. This response was 
dose dependent, reaching maximum stimulation 
at 1 JLM (data not shown). Similar increases 
were also observed with the weak ~agonist 
norepinephrine (data not shown). 
BrcAMP stimulated phosphorylation of IF pro-
teins. 13-Adrenergic hormones such as isoproter-
enol elicit cellular responses through increases 
in the intracellular levels of cAMP. We therefore 
investigated the effects of the cAMP derivative 
BrcAMP and the phosphodiesterase inhibitor 
theophylline on phosphorylation of desmin and 
vimentin in 8-day-old myotubes. Cotreatment of 
these myotubes with BrcAMP and theophylline 
resulted iil a threefold increase in the incorpo-
ration of 32P04 into desmin and vimentin (Fig. 2, 
Table 1) with no apparent increase in labeling for 
tropomyosin. This increase was similar to but 
slightly greater in magnitude than that observed 
in isoproterenol-treated myotubes. The appear-
ance of a third phosphorylated desmin variant, 
more acidic than u'-desmin, can be seen in 
myotubes treated with BrcAMP (Fig. 2B). The-
ophylline alone had no significant effect on IF 
protein phosphorylation (Table 1), and the si-
multaneous inclusion of theophylline and 
BrcAMP did not enhance the effect observed 
with BrcAMP alone (data not shown), consistent 
with the reported resistance of BrcAMP to cellu-
lar phosphodiesterases (15, 16). Most of the 
experiments on the effect of cyclic nucleotides 
were conducted in the presence of theophylline, 
except where noted. The noncyclic analog 
BrAMP had no significant effect on 32P04 incor-
TABLE 1. Response of 7- to 8-day-old myotubes to 
isoproterenol and BrcAMP 
Addition to labeled 
myotubes (amt)" 
Isoproterenol (1 
jiM) 
BrcAMP(0.5 
mM) plus 
theophylline 
(0.5 mM) 
BrcGMP (1 mM) 
plus 
theophylline 
(1 mM) 
Theophylline (1 
mM) 
BrAMP(1 mM) 
BrcAMP (O.S 
mM), 
theophylline 
(1 J.LM), plus 
isoproterenol 
(1 jiM) 
Increase in IF protein 
phosphorylation• No. of 
Total Vimentin 
expts 
desmin 
2.0 ± 0.2 1.8 ± 0.2 3 
2.8 ± 0.2 2.9 ± 0.2 3 
1.4 ± 0.1 2 
1.2 ± 0.2 1.3 ± 0.2 2 
1.1 1.1 1 
3.1 1.9 1 
BrcAMP (0.5 2.9 ± 0.3 2.4 ± 0.5 2 
mM) plus 
theophylline 
(0.5 mM)c 
Isoproterenol (1 1.9 2.2 1 
jLM)c 
" Additions were made during last 45 min of a 4-h 
labeling period. 
• The increase was calculated with tropomyosin 
used as an internal standard to normalize gel loading 
by the following formula: increase = [Oabel in des-
min)/(label in tropomyosin) in experiments] + [(label 
in desmin)/(label in tropomyosin) in controls], ±stan-
dard deviation where applicable. 
c Cells were pretreated with cycloheximide (100 tJ.8/ 
ml) 1 h before hormone or BrcAMP was added; this 
amount was sufli.cient to inhibit greater than 95% of 
protein synthesis within 30 min. 
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FIG. 2. BrcAMP stimulates phosphorylation of 
desmin and vimentin in 7-day-old myotubes. Myo-
tubes were labeled for 4 h with 32P04 (A) and treated 
for 45 min with either 1 mM BrcAMP plus 1 mM 
theophylline (B) or 1 mM BrcGMP plus 1 mM theoph-
ylline (C). BrcAMP plus theophylline resulted in a 
substantial increase in 32P04 incorporation into des-
min (D) and vimentin (V). Note the appearance of 
32P04 in a third acidic desmin species (arrow). Staining 
with Coomassie blue (insets) revealed no changes in 
the ratio of the desmin isoelectric variants in control or 
BrcAMP plus theophylline-treated cells. BrcGMP and 
theophylline (C) had only a slight effect on 32PO• 
incorporation into desmin and vimentin. Autoradio-
grams were exposed for 18 h. 
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poration into IF proteins (Table 1), indicating 
that the increase observed with BrcAMP is 
specific for the cyclic nucleotide. 
To ascertain whether the BrcAMP-induced 
increase in 32P04 incorporation into desmin and 
virnentin represented an actual increase in phos-
phorylation of these proteins, we performed 
several additional experiments. The possibility 
of cAMP-induced increases in protein phosphate 
turnover was ruled out by incubating 8-day-old 
myotubes for 2, 20, or 48 h in 0.5 mM BrcAMP 
and then for 2 h with 32P04 in the presence of 
BrcAMP. No increase in 32P04 incorporation in 
IF proteins was observed compared with paral-
lel untreated cultures (data not shown). 
We have previously reported that phosphor-
ylation of desmin and vimentin is independent of 
protein synthesis (18). We found that the isopro-
terenol- and BrcAMP-induced increases in 
32P04 incorporation into these proteins were 
also independent of protein synthesis. The addi-
tion of cycloheximide 1 h before the addition of 
either isoproterenol or BrcAMP had little effect 
on the subsequent stimulation of 32P04 incorpo-
ration by these agents (Table 1). 
Finally, the specific increase in incorporation 
of 32P04 into the IF proteins (without significant 
increases in other cellular phosphoproteins such 
as tropomyosin) made it unlikely that cAMP 
induced a change in the specific activity of the 
cellular ATP pool, yielding an apparent increase 
in phosphorylation. To confirm this, we deter-
mined the specific activity of the cellular A TP 
pools from control and BrcAMP-treated myo-
tubes by the luciferase A TP assay described by 
Dolecki et al. (4). No differences in the specific 
activity of A TP pools were detected in the 
BrcAMP-treated myotubes in three independent 
experiments (data not shown). From these re-
sults we conclude that the increase in 32P04 
incorporation into desmin and vimentin induced 
by isoproterenol or BrcAMP represents an actu-
al increase in phosphorylation of these two 
proteins. 
When isoproterenol and BrcAMP were ad-
ministered together at concentrations which 
yielded maximal responses when added sepa-
rately (1 ILM isoproterenol, 0.5 mM BrcAMP 
plus theophylline), no additive effect was detect-
ed, yielding a response equivalent to that ob-
served with BrcAMP plus theophylline alone 
(Table 1). This suggests that ~-adrenergic ago-
rusts and BrcAMP act through similar molecular 
mechanisms, presumably via an increase in the 
effective intracellular cAMP level and subse-
quent activation of the cAMP-dependent protein 
kinase. 
Eight-day-old myotubes treated with BrcGMP 
and theophylline showed only slight increases in 
IF protein phosphorylation (Fig. 2C, Table 1) 
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which were less than 25% of the response ob-
served in parallel cultures treated with the iden-
tical concentration of BrcAMP. 
Tryptic analysis or desmin phosphopeptides. 
We have previously used two-dimensional tryp-
tic peptide mapping to compare the phosphopep-
tides from desmin phosphorylated in vivo or in 
vitro by bovine heart cAMP-dependent ~rotein 
kinase (19, 20). A sizable fraction of 3 P04 in 
these earlier preparations migrated as inorganic 
phosphate, suggesting that some hydrolysis of 
phosphopeptides had occurred during sample 
preparation. The use of modified conditions for 
the preparation and digestion of samples for 
peptide mapping resulted in substantially less 
A B 
t c 
a: 
:J: 
(.) 
D 
E 
A o +__..-
c 0 
phosphate hydrolysis. Representative peptide 
maps of 32P04-labeled desmin phosphorylated in 
vivo from 8-day-old myotubes are shown in Fig. 
3. Cultures were incubated with 32P04 for 4 h, 
and BrcAMP-treated ceUs received 1 mM 
BrcAMP during the last hour of the 32P04 incu-
bation. 
The total desmin obtained from 32P04-labeled 
control myotubes exhibited two or three ml\ior 
32P-labeled peptides and several minor species. 
The major peptide designated A and the peptide 
designated B (Fig. 3A) corres~nd to those 
peptides previously identified in 2P-labeled des-
min phosphorylated in vivo or in vitro (20). The 
32P-labeled peptides of desmin from 8-day-old 
• 
ce 
* 
D 
• 
B • 
A b 
* 
D 
D ® 
FIG. 3. T~tic peptide analysis of phosphorylated desmin from 8-day-old myotubes. Myotubes were labeled 
for 4 h with 2P04 (100 J.LCilml) and treated for 1 h with either 1 mM BrcAMP or 1 mM BrAMP. Mapping 
procedures are described in the text. Direction of electrophoresis and chromatography are shown in panel A. 
Panels: (A) Desmin ~m control myotubes: incorporation of 32P04 into five desmin peptides (A-E) was routinely 
observed. (B) Desmm from BrcAMP-treated myotubes: a significant increase in 32P04 incorporation into 
peptides C and Dis apparent. (C) Desmin from BrAMP-treated myotubes: no change in 32P04 incorporation into 
any ~ptide was ob~rved. (D) Desmin phosphorylated in vitro by bovine heart cAMP-dependent protein kinase: 
peptides corresponding to A-D are apparent. The asterisk denotes a prominent peptide seen in labeled in vitro 
desmin which was slightly labeled in BrcAMP-treated myotubes (D) but not in control myotubes (A). 
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myotubes treated with BrcAMP were qualita-
tively similar to those of control untreated des-
min. The most noticeable difference was a large 
increase in 32P04 incorporation into the peptides 
designated C and D (Fig. 3B). Table 2 shows the 
32P04 incorporated into each of the five phos-
phopeptides shown in Fig. 3A and B. The rela-
tive incorporation (normalized to peptide A) is 
also shown (data obtained from two independent 
experiments). There was an approximate 7- to 
10-fold increase in the incorporation of 32P04 
into peptides C and D, whereas peptides A, B, 
and E remained unchanged. This increase was 
sufficient to account for a 2.5-fold increase in 
32P04 incorporation into total desmin. Compari-
son of a- and a'-desmin from BrcAMP-treated 
cells revealed little qualitative difference; both 
a- and a'-desmin showed increases in 32P04 
incorporation into peptides C and D (data not 
shown). Treatment of cells with BrAMP had no 
effect on the phosphorylation of desmin peptides · 
(Fig. 3C, Table 2), consistent with the lack of 
increased 32P04 incorporation into BrAMP-
treated myotubes. 
We have previously reported that desmin pep-
tides A and B are · phosphorylated at serine 
residues (20). Partial acid hydrolysis of peptides 
C and D revealed that they also contain serine as 
the phosphorylated amino acid (data not 
shown). 
Comparison of the phosphopeptide maps of 
desmin labeled in vivo with desmin phosphory-
lated in vitro by bovine heart cAMP-dependent 
protein kinase revealed several similarities. Pep-
tides A-D were clearly identifiable in both the in 
vivo and the in vitro labeled desmin (Fig. 3A and 
D). Peptide E, which was present in the in vivo 
labeled desmin, was not apparent in desmin 
labeled in vitro. A prominent peptide (Fig. 3D, 
asterisk) observed in the desmin labeled in vitro 
was not apparent in the control myotubes la-
MoL. CELL. BIOL. 
beled in vivo (Fig. 3A), but was weakly labeled 
in BrcAMP-treated myotubes (Fig. 3B). 
The relative occupancy of the observed des-
min peptides under normal growth conditions 
were determined by labeling 8-day-old myotubes 
with 32P04 for intervals of 2 to 24 h in minimal 
essential medium supplemented with 10% horse 
serum and 2% chicken embryo extract. Total 
incorporation of 32P04 into desmin was ob-
served to approach a plateau by 24 h (data not 
shown). The incorporation into individual pep-
tides at 24 h and the incorporation relative to 
total 32P04 in desmin is shown in Table 2. We 
concluded that the incorporation of 32P01 into individual peptides relative to the total 2P04 
incorporated into desmin represents the relative 
occupancy of each of the phosphorylation sites 
on desmin. Peptides C and D together represent-
ed only approximately 7% of the total phosphate 
in desmin (Table 2). 
Phosphorylation during myogenesis. Incorpo-
ration of radioactive phosphate into both des min 
and vimentin was observed during all stages of 
myogenesis in vitro. In secondary myogenic 
cultures at 6 h after being plated, which consist 
predominantly of unfused replicating myoblasts, 
vimentin is the major IF protein, whereas des-
min is a minor protein species restricted to the 
few fusing myoblasts or young myotubes (9). 
Although 32P04 incorporation was greatest in 
vimentin (Fig. 4A and B), a 32P04-labeled spe-
cies identifiable as a-desmin was detectable 
(Fig. 4A, arrow). By 24 h after plating phosphor-
ylated desmin was prevalent, with both a- and 
a'-desmin identifiable (data not shown). At later 
stages (4, 7, or 19 days), desmin represented one 
of the major cellular phosphoproteins along with 
vimentin and tropomyosin (see Fig. 1, 2, 4B, and 
C). The observed increase in phosphorylated 
desmin presumably parallels the increase in syn-
thesis of desmin and its cytoplasmic accumula-
TABLE 2. Incorporation of label into desmin phosphopeptides 
32PQ4 incorporation into 8-day-old myotubes with": 
Peptide No addition BrcAMP (1 mM, 1 h) BrAMP (1 mM, 1 h) 24-h incubation• 
p R p R p R p R 0 
A 1,077 1.0 764 1.0 651 1.0 923 1.0 0.65 
B 174 0.14 ± 0.02 128 0.15 ± 0.02 106 0.15 ± 0.03 165 0.18 0.12 
c 151 0.18 ± 0.04 1,651 2.1 ± 0.07 93 0.15 ± 0.01 80 0.09 0.06 
D 63 0.06 ± 0.01 336 0.40 ± 0.04 32 0.04 ± 0.01 12 0.01 0.01 
E 285 0.21 ± 0.05 208 0.24 ± 0.04 165 0.22 ± 0.03 231 0.25 0.16 
Total 1,750 1.6 ± 0.1 3,087 3.9 ± 0.2 1,047 1.6 ± 0.1 1,411 1.5 1.0 
" Myotubes were labeled for 4 h with 32P04 (1~ jLCilml): and Brc~ or Br~P was add~. P, T~tal 32P04 
label incorporation per peptide (one representative expenment); R, mcorporation of label mto peptides B-E 
relative to peptide A (two experiments ± range). 
b Myotubes were labeled with 32P04 (200 ILCilml) for 24 h (see the text) to determine the re~tive occu~cy 
(0) of each peptide (0 equals amount of label in individual peptide divided by amount of label m total desnun). 
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FIG. 4. Phosphorylation during myogenesis. Myogenic cultures were labeled for4 h with 32P04• BrcAMP and 
theophylline were added during the last 45 min to final concentrations of 1 mM (panels D and E) or 0.5 mM (panel 
F). Phosphorylation of desmin (D) and vimentin (V) was apparent in control cultures at all times examined. In 6-h 
myoblasts (A), desmin (arrow) is a minor component (see text). After 4 (B) and 19 (C) days, desmin represents 
one of the major cellular phosphate acceptors. No increase in 32P04 incorporation into desmin or vimentin was 
seen in BrcAMP-treated myoblasts (D) or 4-day-old myotubes (E). Previous figures (1-3) showed significant 
BrcAMP-induced phosphorylation increases in 7- to 8-day-old myotubes. This increase was also ap~arent in 19-
day-old myotubes (panel F). Arrows in D indicate a-, a'-, and a third desmin variant. T, Tropomyosin; •, a 
cellular phosphoprotein which is diminished in 19-day-old myotubes. Autoradiograms were exposed for 24 h. 
tion during myogenesis (9). Several other phos-
phoproteins were present in altered amounts 
during myogenesis. For example, 32P-labeled 
muscle tropomyosin is a very minor component 
in 6-h cultures, but increases substantially dur-
ing myogenesis as the intracellular concentra-
tion of tropomyosin increases (9). Conversely, 
phosphorylation of another prominent cellular 
protein prevalent in early myoblasts was sub-
stantially reduced during the course of differen-
tiation (Fig. 4, asterisks). A phosphoprotein with 
similar pi and electrophoretic mobility was also 
observed in non-muscle chicken embryo fibro-
blast cultures and BHK-21 cells (data not 
shown). This protein was not identified. 
No changes in the phosphorylation of desmin 
and vimentin were apparent in autoradiograms 
from isoproterenol- or BrcAMP-treated myo-
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blasts (Fig. 4A and D) or early myotubes (Fig. 
4B and E; isoproterenol data not shown). This 
was in contrast to the increased phosphorylation 
induced by either BrcAMP or isoproterenol in 7-
to 8-day-old cultured myotubes (Fig. 1 and 2) 
and in 19-day-old cultured myotubes (Fig. 4C 
and F). These data suggest that the increase in 
IF protein phosphorylation stimulated by hor-
mones or cAMP is restricted to mature myo-
tubes (greater than 7 days in culture). 
Phosphopeptide maps of desmin from control 
or BrcAMP-treated 3-day-old myotube cultures 
appeared to be qualitatively similar to those 
from 8-day-old cultures. However, no increase 
in 32P04 incorporation into peptides C, D, or any 
other peptide was observed in BrcAMP-treated 
3-day-old myotubes, consistent with the lack of 
response of early myotubes to BrcAMP or iso-
proterenol (data not shown). 
DISCUSSION 
The IF proteins desmin and vimentin are two 
of the major cellular phosphoproteins present in 
8-day-old cultures of chicken skeletal myotubes. 
The addition of either isoproterenol or BrcAMP 
during the last 45 min of a 32P04 incubation 
resulted in a two- to threefold stimulation of 
32P04 incorporation into both of these IF pro-
teins. Although the magnitude of the increase in 
phosphorylation was not large, it was consistent 
and dependent upon the dose of isoproterenol or 
BrcAMP administered. cAMP-induced synthe-
sis of IF proteins and subsequent phosphoryla-
tion was not repsonsible for the observed in-
crease in 32P04 incorporation as shown by a lack 
of sensitivity to the protein synthesis inhibitor 
cycloheximide (Table 1). The possibility that 
BrcAMP induces an increase in the turnover 
rate of protein phosphate by activation of a 
phosphoprotein phosphatase, yielding an appar-
ent increase in IF protein phosphorylation, was 
made unlikely by the lack of increased 32P04 
incorporation into desmin and vimentin in myo-
tubes treated for 2 to 48 h with BrcAMP before 
being labeled with 32P04• Finally, BrcAMP was 
found to have no effect on the incorporation of 
32P04 into the cellular A TP pool. From these 
data we concluded that ~-adrenergic hormones 
such as isoproterenol and cAMP derivatives 
such as BrcAMP stimulate actual increases in 
the phosphorylation of the IF proteins desmin 
and vimentin in 8-day-old myotubes. The lack of 
response to added BrAMP indicated specificity 
for cyclic nucleotides. BrcAMP has been shown 
to be a potent activator of the cAMP-dependent 
protein kinases (16), suggesting that these en-
zymes are responsible for the observed increase 
in phosphorylation. The lack of an additive 
response when isoproterenol and BrcAMP were 
added at saturating concentrations to the same 
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culture supports the conclusion that these agents 
act through a common pathway, via an elevation 
in the effective intracellular levels of cAMP and 
subsequent activation of the cAMP-dependent 
protein kinases. The slight stimulation of IF 
protein phosphorylation by BrcGMP may indi-
cate additional phosphorylation of these pro-
teins by the cGMP-dependent protein kinase. 
Alternatively, BrcGMP has been shown to be a 
weak activator of cAMP-dependent protein ki-
nases in vitro (16), and the concentrations of 
BrcGMP used in our experiments might have 
resulted in such activation. 
Under the conditions employed for these ex-
periments, no changes in protein phosphoryla-
tion aside from those of IF proteins were 
consistently observed in BrcAMP- or isoproter-
enol-treated myotubes. Small changes in phos-
phate incorporation, minor protein components, 
or components outside the pH range (4.3 to 6.2) 
of our gel system might have been missed. In 
contrast to other reports of cAMP-modulated 
phosphorylation of actin in S49 mouse lympho-
ma cells (24), we observed no 32P04 incorpo-
ration into any actin species. 
We previously reported the presence of two 
major phosphopeptides in desmin radiolabeled 
with 32fo4 in vivo (20). In this report modifica-
tions of our labeling protocol and tryptic mapping 
procedures allowed the identification of addi-
tional peptides. Of the five desmin phosphopep-
tides now identified, two were shown to be 
modulated by cAMP in vivo. Treatment of ma-
ture myotubes with BrcAMP resulted in a 7- to 
10-fold increase in 32P04 incorporation into 
these two peptides (Fig. 3, peptides C and D). 
Both of these peptides were found to contain o-
phosphoserine as the phosphorylated amino 
acid. Incorporation of 32P04 into these peptides 
was also dependent upon myotube culture con-
ditions and could be markedly reduced by serum 
starvation (unpublished data). 
Four of the five desmin phosphopeptides ob-
served in vivo, including peptides C and D, were 
also identified in 32P-labeled desmin phosphory-
lated in vitro by cAMP-dependent protein ki-
nase. Although the phosphorylation of sites cor-
responding to these peptides by another kinase 
with identical specificity cannot be ruled out, 
this evidence suggests that most of the desmin 
phosphopeptides are phosphorylated by the 
cAMP-dependent protein kinase. The differ-
ences noted between the relative labeling of the 
desmin phosphopeptides in vivo and in vitro 
presumably reflects factors including site acces-
sibility and occupancy in vivo rather than dis-
tinct kinase specificities. Of the in vivo desmin 
phosphopeptides, only peptide E could not be 
identified in demsin phosphorylated in vitro. We 
can draw no conclusions about the kinase re-
VoL. 2,1982 cAMP PHOSPHORYLATION OF INTERMEDIATE FILAMENTS 1113 
sponsible for phosphorylating peptide E at this 
time. 
We previously concluded that the most basic 
species of desmin and vimentin represent the 
unmodified translation products and that subse-
quent phosphorylation reactions give rise to the 
more acidic variants (19). We were thus puzzled 
by the lack of perceptible changes in the ratio of 
desmin isoelectric species after BrcAMP-in-
duced increases in phosphorylation. Because 
the 32P04 labeling period used (4 h in most 
experiments) was significantly shorter than that 
required for phosphorylated IF proteins to reach 
a constant specific activity equal to that of the 
cellular ATP pool, the relative increase in 32P04 
incorporation which we report for BrcAMP or 
isoproterenol was disproportionate to the actual 
increase in phosphorylation. The two- to three-
fold increase in total 32P04 in desmin (corre-
sponding to a seven- to tenfold increase in 32P04 
in peptides C and D) cannot be construed as 
representing a two- to threefold increase in total 
phosphorylation of desmin. The lack of a detect-
able dift"erence in the ratio of Coomassie-stained 
desmin variants after treatment with BrcAMP 
suggests that the actual increase must be less. 
Based upon our estimates of the relative occu-
pancy of the desmin phosphorylation sites A-E 
(corresponding to peptides A-E) under normal 
growth conditions (Table 2), a twofold increase 
in actual phosphorylation at sites C and D would 
result in an increase ofless than 10% in the total 
phosphate in desmin. Such an increase, when 
distributed among the desmin isoelectric vari-
. ants, could result in changes in the ratios of the 
desmin isoelectric variants which are below the 
resolution of our techniques. 
Phosphorylation of both desmin and vimentin 
was apparent at all stages of myogenesis exam-
ined. However, the sensitivity of phosphoryla-
tion to stimulation by BrcAMP or isoproterenol 
was observed only in mature myotubes (7 to 8 
days after culture). The basis for this difference 
in sensitivity during myogenesis is not yet 
known. Both cAMP levels and levels of active 
cAMP-dependent protein kinase have been 
shown to vary during early myogenesis (28). It is 
possible that in early myoblast or myotube cul-
tures higher endogenous cAMP levels may re-
sult in maximal phosphorylation of cAMP-mod-
ulated sites. The addition of exogenous cAMP 
could not then stimulate 32P04 incorporation 
into IF proteins over that caused by turnover of 
previously bound phosphate. It is interesting 
that the two non-muscle cell types examined 
responded differently to BrcAMP and isoproter-
enol. Increases in phosphorylation of vimentin 
were observed in chicken embryo fibroblast 
cells treated with BrcAMP or isoproterenol, but 
no increases were seen in similarly treated 
BHK-21 cells, which contain both desmin and 
vimentin (unpublished data; see also references 
3 and 5). This also might reflect differences in 
endogenous intracellular cAMP levels. 
The function of IF phosphorylation has not 
been conclusively established. No differences in 
the polymerization properties of BHK cell IF 
proteins in the phosphorylated or unphosphory-
lated state have been detected (26, 27). Similar-
ly, phosphorylation has no observable effect on 
the assembly of desmin and vimentin into Tri-
ton-KCl-insoluble myotube cytoskeletons (18); 
the BrcAMP-stimulated increase in myotube IF 
protein phosphorylation observed in whole cell 
extracts was also seen in analyses of cytoskele-
tons treated with Triton X-100 (unpublished 
data). We find it intriguing, however, that the 
increase in sensitivity of IF protein phosphoryla-
tion during myogenesis corresponded chrono-
logically with the redistribution of cytoplasmic 
IFs to the myofibril Z line during late myogene-
sis which we described previously (9). Although 
the mechanisms which regulate this reorganiza-
tion of IFs are, as yet, unknown, this coinci-
dence suggests that phosphorylation of IF pro-
teins by cAMP-dependent protein kinase may be 
involved. Preliminary immunofluorescence 
studies indicate that treatment of myotubes with 
either BrcAMP or isoproterenol can reversibly 
inhibit this redistribution ofiFs to the Z line. We 
are tempted to speculate that this inhibition is 
related to the observed increases in phosphor-
ylation of IF proteins stimulated by these 
agents . 
In summary, we have reported that ~-adrener­
gic agonists such as isoproterenol and cAMP 
analogs stimulate increases in the phosphoryla-
tion of the IF proteins desmin and vimentin in 8-
day-old myotubes cultured in vitro and have 
identified specific desmin phosphopeptides 
whose phosphorylation is increased in BrcAMP-
treated 8-day-old myotubes. Although mature 
(7- to 8-day-old) myotubes showed increases in 
phosphorylation, myoblasts showed no changes 
in phosphorylation when exposed to either ago-
rusts or cAMP analogs. These data, in conjunc-
tion with our previous studies of cAMP-depen-
dent phosphorylation of desmin and vimentin in 
vitro (18, 19), suggest that the IF proteins des-
min and vimentin are phosphorylated by the 
cAMP-dependent protein kinase in vivo and that 
changes in intracellular cAMP levels during dif-
ferentiation may modulate IF protein phosphor-
ylation and thereby regulate IF function. 
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